TELMISARTAN tablet United States - English - NLM (National Library of Medicine)

telmisartan tablet

proficient rx lp - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq) - telmisartan 80 mg - telmisartan is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacol

TWYNSTA 80/10 telmisartan 80 mg/amlodipine 10 mg (as besilate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

twynsta 80/10 telmisartan 80 mg/amlodipine 10 mg (as besilate) tablet blister pack

boehringer ingelheim pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: povidone; microcrystalline cellulose; maize starch; pregelatinised maize starch; sodium hydroxide; magnesium stearate; colloidal anhydrous silica; meglumine; sorbitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

TWYNSTA  40/5 telmisartan 40 mg/amlodipine 5 mg (as besilate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

twynsta 40/5 telmisartan 40 mg/amlodipine 5 mg (as besilate) tablet blister pack

boehringer ingelheim pty ltd - telmisartan, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, multilayer - excipient ingredients: magnesium stearate; meglumine; sorbitol; sodium hydroxide; microcrystalline cellulose; povidone; colloidal anhydrous silica; maize starch; pregelatinised maize starch; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

TWYNSTA 40/10 telmisartan 40 mg/amlodipine 10 mg (as besilate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

twynsta 40/10 telmisartan 40 mg/amlodipine 10 mg (as besilate) tablet blister pack

boehringer ingelheim pty ltd - telmisartan, quantity: 40 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, multilayer - excipient ingredients: colloidal anhydrous silica; sodium hydroxide; sorbitol; magnesium stearate; pregelatinised maize starch; povidone; microcrystalline cellulose; maize starch; meglumine; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

TWYNSTA 80/5 telmisartan 80 mg/amlodipine 5 mg (as besilate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

twynsta 80/5 telmisartan 80 mg/amlodipine 5 mg (as besilate) tablet blister pack

boehringer ingelheim pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; meglumine; magnesium stearate; maize starch; colloidal anhydrous silica; sodium hydroxide; povidone; sorbitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

APO-Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APX-PERINDOPRIL ARGININE/ AMLODIPINE 10/5 perindopril arginine 10 mg/ amlodipine 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine/ amlodipine 10/5 perindopril arginine 10 mg/ amlodipine 5 mg uncoated tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.935 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Olmesartan medoxomil/Amlodipine 40 mg/5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine 40 mg/5 mg film-coated tablets

accord healthcare limited - amlodipine (as amlodipine besilate ph. eur.); olmesartan medoxomil - film-coated tablet - 40/5 mg/mg - angiotensin ii antagonists and calcium channel blockers; olmesartan medoxomil and amlodipine

Olmesartan medoxomil/Amlodipine 40 mg/10 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine 40 mg/10 mg film-coated tablets

accord healthcare limited - amlodipine (as amlodipine besilate ph. eur.); olmesartan medoxomil - film-coated tablet - 40/10 mg/mg - angiotensin ii antagonists and calcium channel blockers; olmesartan medoxomil and amlodipine

APO-TELMISARTAN HCTZ 80/12.5mg   telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-telmisartan hctz 80/12.5mg telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; sodium hydroxide; mannitol; meglumine; sodium stearylfumarate; purified water; iron oxide red - apo telmisartan hctz is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.